Paula Ragan
2021
In 2021, Paula Ragan earned a total compensation of $2.1M as President and Chief Executive Officer at X4 Pharmaceuticals, a 15% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $309,330 |
---|---|
Salary | $562,126 |
Stock Awards | $1,258,272 |
Other | $11,600 |
Total | $2,141,328 |
Ragan received $1.3M in stock awards, accounting for 59% of the total pay in 2021.
Ragan also received $309.3K in non-equity incentive plan, $562.1K in salary and $11.6K in other compensation.
Rankings
In 2021, Paula Ragan's compensation ranked 5,795th out of 12,415 executives tracked by ExecPay. In other words, Ragan earned more than 53.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,795 out of 12,415 | 53rd |
Division Manufacturing | 2,457 out of 5,508 | 55th |
Major group Chemicals And Allied Products | 1,066 out of 2,378 | 55th |
Industry group Drugs | 949 out of 2,099 | 55th |
Industry Biological Products, Except Diagnostic Substances | 232 out of 449 | 48th |
Source: SEC filing on April 25, 2022.
Ragan's colleagues
We found two more compensation records of executives who worked with Paula Ragan at X4 Pharmaceuticals in 2021.
News
X4 Pharmaceuticals CEO Paula Ragan's 2022 pay jumps 81% to $3.9M
April 25, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021
X4 Pharmaceuticals CEO Paula Ragan's 2019 pay jumps 171% to $2.5M
April 28, 2020
X4 Pharmaceuticals CEO René BCPS' 2018 pay jumps 188% to $3.4M
May 22, 2019